HFA Premium Access

Intramyocardial injections of the continuous erythropoietin receptor activator (CERA) in patients with chronic ischemic cardiomyopathy. Results of the randomized study

Congress Presentation

About the speaker

Mr Denis Losik

eMed Support, Dubai (United Arab Emirates)
2 presentations
1 follower

13 more presentations in this session

Morbidity, mortality, and cost impact of stage b and stage c heart failure: comparative analysis to underline the clinical and economic need for heart failure prevention strategy.

Speaker: Doctor S. James (Dublin, IE)


Effects of 5 years treatment with nebivolol, carvedilol and bisoprolol in heart failure patients

Speaker: Doctor G. Marazzi (Rome, IT)


MTP-131, a cardiolipin-targeting peptide, improves mitochondrial activity in the failing human heart

Speaker: Doctor B. Stauffer (Aurora, US)


Is the cohort of paradigm-hf representative of the real world population of patients with systolic heart failure?

Speaker: Doctor G. Rocha Rodrigues (Lisbon, PT)


Evidence-based medications in multi-ethnic Asian patients with heart failure are associated with better outcomes in spite of lower doses

Speaker: Doctor T. Teng (Singapore, SG)


Access the full session

Rapid Fire 3 - Chronic heart failure management

Speakers: Mr D. Losik, Doctor S. James, Doctor G. Marazzi, Doctor B. Stauffer, Doctor G. Rocha Rodrigues...

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb